Table 1

Association of CST6 methylation status with clinicopathological features for the independent group (n = 80)
Clinicopathological features CST6methylation
n + (%) - (%) P value*
Age (years) <55 42 22 (52.4) 20 (47.6) 0.495
≥55 38 17 (44.7) 21 (55.3)
Menopausal status Pre 34 18 (52.9) 16 (47.1) 0.519
Post 46 21 (45.7) 25 (54.3)
Tumor size (cm) 0-2.0 23 11 (47.8) 12 (52.2) 0.682
2.1-5.0 48 22 (45.8) 26 (54.2)
>5.0 8 5 (62.5) 3 (37.5)
Axillary lymph node 0 23 9 (39.1) 14 (60.9) 0.366
1-3 28 14 (50.0) 14 (50.0)
≥4 27 16 (59.3) 11 (40.7)
Tumor grade Ι 22 8 (36.4) 14 (63.6) 0.172
ΙΙ, ΙΙΙ 58 31 (53.4) 27 (46.6)
Estrogen receptor Positive 49 22 (44.9) 27 (55.1) 0.386
Negative 31 17 (54.8) 14 (45.2)
Progesterone receptor Positive 26 10 (38.5) 16 (61.5) 0.201
Negative 54 29 (53.7) 25 (46.3)

*: Chi-square test.

Dimitrakopoulos et al.

Dimitrakopoulos et al. BMC Cancer 2012 12:486   doi:10.1186/1471-2407-12-486

Open Data